ÂÜÀòÂÒÂ×

Chief Investment Officer, Karolinska Development Viktor Drvota has over 13 years of Venture Capital experience with several investments, significant fundraisings, IPOs, and exits. He was responsible for Life Science at SEB Venture Capital from 2002 to 2016. During his tenure at SEB VC, he also served as a board member in several biotechs and MedTech companies such as Arexis AB, SBL Vaccin AB, Nuevolution AS, Index Pharma AB, Scibase AB, and Airsonett AB, among others. Before joining SEB, Dr. Drvota worked as Senior Consultant and Associate Professor in Cardiology at Karolinska University Hospital, Stockholm. Dr. Drvota has experience in preclinical as well as clinical research in drug development and medical devices. Dr. Drvota has 29 published research articles.